• About
    • Our Story
    • Our Vision/Mission
    • Our Team
    • Pressroom
  • For Families
    • What is LCA?
    • ‘Let’s Chat About…’
    • ID Your Gene
    • Clinical Trials
    • Resources
    • Rare Retinal Disease Glossary
    • Family Connections
    • Hope in Focus Ambassadors
  • Stories
    • Posts & Videos
    • Photo Gallery
  • Get Involved
    • Dinner in the Dark 2022
    • Event Calendar
    • Donate
  • Contact
    • Get in Touch
    • Email & Newsletter Sign Up
    • Family Connections
  • DONATE
    Leber Congenital Amaurosis Leber Congenital Amaurosis Leber Congenital Amaurosis Leber Congenital Amaurosis
    • About
      • Our Story
      • Our Vision/Mission
      • Our Team
      • Pressroom
    • For Families
      • What is LCA?
      • ‘Let’s Chat About…’
      • ID Your Gene
      • Clinical Trials
      • Resources
      • Rare Retinal Disease Glossary
      • Family Connections
      • Hope in Focus Ambassadors
    • Stories
      • Posts & Videos
      • Photo Gallery
    • Get Involved
      • Dinner in the Dark 2022
      • Event Calendar
      • Donate
    • Contact
      • Get in Touch
      • Email & Newsletter Sign Up
      • Family Connections
    • DONATE

    Archives

    Monthly Archive for: "January, 2022"
    0
    By Rosanne Smyle
    In Blog
    Posted January 28, 2022

    Let’s Chat About…ProQR’s Work in Treatments for Inherited Retinal Disease

    ProQR Therapeutics’ Founder and Chief Executive Officer shared exciting news of the deep pipeline of RNA therapies in development to treat Leber congenital amaurosis (LCA) and other [...]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted January 17, 2022

    Let’s Chat About…Gene Therapy News for LCA13, LCA1, LCA2, and LCA4

    One of Britain’s top Ophthalmologist’s delivered promising research news on several forms of Leber congenital amaurosis, including LCA13 (RDH12), LCA1 (GUCY2D), LCA2 (RPE65), and LCA4 (AIPL1). [...]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted January 8, 2022

    Family Excited About New LCA5-Lebercilin Research Program

    John Mills says he would crawl over broken glass if it led to a cure for his daughter’s visual impairment caused by one of the rarest of rare inherited retinal […]

    READ MORE
    Sign Up for Our Newsletter
    NEWSLETTER SIGN UP
    Get In Touch
    • 860-266-6062
    • info@hopeinfocus.org
    Follow Us
    Hope in Focus is a 501(C)(3). © All rights reserved.
    Please read our Privacy Promise.
    Skip to content
    Open toolbar

    Accessibility Tools

    • Increase Text
    • Decrease Text
    • Grayscale
    • High Contrast
    • Negative Contrast
    • Light Background
    • Links Underline
    • Readable Font
    • Reset